Serial Number 98210413
731

Registration Progress

Application Filed
Oct 5, 2023
Under Examination
Mar 26, 2024
Approved for Publication
Jan 30, 2024
Published for Opposition
Jan 30, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Sep 26, 2025 78 days

Trademark Image

Basic Information

Serial Number
98210413
Deadline
September 26, 2025
Description
Statement of Use or 3rd Extension Due
Filing Date
October 5, 2023
Published for Opposition
January 30, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
731
Status Date
Mar 14, 2025
Application
Pending
Classes
005

Rights Holder

FIBROGEN, INC.

03
Address
350 Bay Street, Suite 100 #6009
San Francisco, CA 94133

Ownership History

AstraZeneca AB

Original Applicant
03
Södertälje SE

AstraZeneca AB

Owner at Publication
03
Södertälje SE

FIBROGEN, INC.

New Owner After Publication #1
03
San Francisco, CA

Legal Representation

Attorney
Harold Milstein

USPTO Deadlines

Next Deadline
78 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
September 26, 2025
Extension Available
Until March 26, 2025

Application History

30 events
Date Code Type Description
Mar 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2025 EX2G S SOU EXTENSION 2 GRANTED
Mar 14, 2025 EXT2 S SOU EXTENSION 2 FILED
Mar 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 7, 2024 EWOR I TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Oct 7, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 7, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 7, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2024 EX1G S SOU EXTENSION 1 GRANTED
Aug 27, 2024 EXT1 S SOU EXTENSION 1 FILED
Aug 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 26, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 26, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 26, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 26, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 26, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 26, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 3, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jan 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 22, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2023 DOCK D ASSIGNED TO EXAMINER
Oct 14, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 13, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, gastrointestinal diseases and disorders

Additional Information

Design Mark
The mark consists of two semi-circle shapes and six triangle shapes forming a curved geometric design.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005